Latest projects

3rd Health Programme (2014-2020)
EURORDIS SGA2021 [SGA 2021]
The application for the Specific Grant Agreement 2021 continues the work of EURORDIS - Rare Diseases Europe as described within the Framework Partnership 2018-21.
EURORDIS key operational objectives f...
The application for the Specific Grant Agreement 2021 continues the work of EURORDIS - Rare Diseases Europe as described within the Framework Partnership 2018-21.
EURORDIS key operational objectives for 2021 build on the work of the previous work around the 4 overarching objectives:
1 Consolidating the rare disease community
2 Actively engaging RD patient representatives into the effective implementation and monitoring of legislation and strategies
3. Building capacities and empowering members and volunteers
4. Sustaining human, financial and organisational resources
Start date: 01/01/2021 - End date: 31/12/2021

Call: Invitation to submit proposals for Specific Operating Grants (SGA) for the year 2021 under the Annual Work Programme 2020 of 3HP
Topic: 3rd Health Programme (2014-2020) - Priorities
3rd Health Programme (2014-2020)
THALassaemia In Action 2021 [THALIA2021]
Thalassaemia, a previously fatal childhood genetic disease, can today be effectively prevented and appropriately treated, as a result of medical and scientific advances in the last three decades. Howe...
Thalassaemia, a previously fatal childhood genetic disease, can today be effectively prevented and appropriately treated, as a result of medical and scientific advances in the last three decades. However, thalassaemia’s prioritisation on national health agendas and the development of national plans for its effective control in the EU has been hampered by the many challenges involved, mainly related to its rarity and migration.

THALassaemia In Action 2021 (THALIA2021) focuses on Europe, targeting patients with thalassaemia and other haemoglobinopathies, healthcare professionals and policymakers and aims to attain four general objectives, based on TIF’s main pillars of activities:

1. Continue and strengthen the education of patients/parents and healthcare professionals, as well as the patients’ capacity, competency and networking within and across countries and regions of Europe. This is to be achieved via the development of e-learning tools and the launching of capacity building courses and training seminars.

2. Raise awareness on thalassaemia and the importance of optimal care amongst the public at large, as well as among THALIA target groups at national and European level. This will be attained using an array of online tools, activities and publications.

3. Prioritise haemoglobin disorders and their control (prevention and management) at European level. This will be accomplished by establishing and training national patients’ associations in EU priority countries, creating an EU Electronic Health Record and entering into policy dialogue with policymakers at national and European level.

4. Support research programmes and studies focused on the clinical management of Thalassaemia. This is to be achieved via the publication of guidelines on the clinical management of Thalassaemia, participating in scientific conferences and providing fellowships to medical specialists.

Knowledge is our power. Unity is our strength.
Start date: 01/01/2021 - End date: 31/12/2021

Call: Invitation to submit proposals for Specific Operating Grants (SGA) for the year 2021 under the Annual Work Programme 2020 of 3HP
Topic: 3rd Health Programme (2014-2020) - Priorities
3rd Health Programme (2014-2020)
OBesity Training And Information Services in Europe - phase 2 [OBTAINS-E2_2021]
This is the final year of a proposed 4-year Framework Partnership Agreement (FPA). It builds on the actions under a previous Framework Partnership Agreement, OBTAINS-E, supported by the 3rd Health Pro...
This is the final year of a proposed 4-year Framework Partnership Agreement (FPA). It builds on the actions under a previous Framework Partnership Agreement, OBTAINS-E, supported by the 3rd Health Programme. OBTAINS-E is the acronym for OBesity Training And Information Services in Europe.

The OBTAINS-E2 programme contributes to the EU 3rd Health Programme and its priorities for preventing disease and supporting healthy lifestyles, reducing health inequalities, promoting cross-border medical expertise (including rare causes of obesity), and supporting evidence-based and cost-effective prevention and health promotion activities. OBTAINS-E2 will support access to best-practice weight management services for all citizens, along with high quality information available to all, with a special focus on inequalities and the development of policies to tackle obesity across the region.

In 2021, OBTAINS-E2 will focus on:
a) training of health care professionals through expansion of an online e-learning platform of obesity training
b) Improving data availability for Europe and information on European interventions to address obesity and
c) supporting policy development through an evidence repository, briefing papers and webinar series.
Start date: 01/01/2021 - End date: 31/12/2021

Call: Invitation to submit proposals for Specific Operating Grants (SGA) for the year 2021 under the Annual Work Programme 2020 of 3HP
Topic: 3rd Health Programme (2014-2020) - Priorities
3rd Health Programme (2014-2020)
EUROPEAN CANCER LEAGUES COLLABORATING FOR IMPACT IN CANCER CONTROL (2021) [ECL SGA 2021]
The Association of European Cancer Leagues (ECL) provides a unique platform as the only organisation with the mission of uniting at the European level, national and regional cancer leagues to achieve ...
The Association of European Cancer Leagues (ECL) provides a unique platform as the only organisation with the mission of uniting at the European level, national and regional cancer leagues to achieve a cancer-free Europe. In coherence with the FPA 2018-2021, and building upon the outcomes from previous years of the FPA, this proposal focuses on the core activities to be implemented in 2021 in respect of the following strategic objectives:

1) Ensuring cancer control remains high on the political agenda;
2) Promoting the European Code Against Cancer (ECAC) as the essential tool for cancer prevention;
3) Supporting the implementation of the Council Recommendation on Cancer Screening (2003); and
4) Uniting leagues to advocate for equal access to treatment, support, and rehabilitation for cancer patients;
5) Advocating for the European Guide for quality improvement in cancer control to be mainstreamed in national cancer plans.
These objectives will be achieved by several actions, including:

- Implementing the MEPs against Cancer (MAC) 2019 elections manifesto and supporting with a toolkit to commemorate World Cancer Day;
- Publishing a communication guideline for cancer leagues to promote the European Week against cancer (EWAC);
- Developing the viewpoint of cancer leagues on the future of the European Code against Cancer (ECAC) based on the findings of the ECAC evaluation;
- Create a special tutorial on the background and application of the ECAC for young advocates in the ECL Youth Ambassadors programme;
- Supporting the roadmap towards a 3rd implementation report on cancer screening in the EU;
- Releasing the updated edition of the Patient Support Working Group Rehabilitation Atlas;
- Continuation of the advocacy work of the ECL Access to Medicines Task Force implementing the 2018 'Let's Talk Access'
White Paper on Equal Access to Medicines.
Start date: 01/01/2021 - End date: 31/12/2021

Call: Invitation to submit proposals for Specific Operating Grants (SGA) for the year 2021 under the Annual Work Programme 2020 of 3HP
Topic: 3rd Health Programme (2014-2020) - Priorities
3rd Health Programme (2014-2020)
Optimise the journey from donor recruitmento to stem cell transplant [SAVDON]
WMDA is an association that strives to faciliate the best possible stem cell source for transplant patients. This is achieved by member organisations that collaborate so that more patients are able to...
WMDA is an association that strives to faciliate the best possible stem cell source for transplant patients. This is achieved by member organisations that collaborate so that more patients are able to find the best possible stem cell source. In addition, WMDA strives to have high quality products available. On the other side, WMDA promotes donor care by protecting the righs and safety of the donor.
Start date: 01/01/2021 - End date: 31/12/2021

Call: Invitation to submit proposals for Specific Operating Grants (SGA) for the year 2021 under the Annual Work Programme 2020 of 3HP
Topic: 3rd Health Programme (2014-2020) - Priorities